Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teresa Pacifico

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Biomedicines|July 29, 2023
Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus BarrierCarmine Stolfi, Teresa Pacifico, Giovanni Monteleone, et al.
Biomedicines|May 27, 2026
From Gut Homeostasis to Colorectal Cancer: Spatial and Temporal Reprogramming of Microbial Inosine SignalingLorenzo Tomassini, Teresa Pacifico, Giovanni Monteleone, et al.
Cells|December 24, 2025
Targeting Cancer Cell Energy Metabolism in Colorectal Cancer: Opportunities and Challenges from Drug RepositioningLorenzo Tomassini, Teresa Pacifico, Giovanni Monteleone, et al.
International Journal of Molecular Sciences|April 13, 2023
Anthelmintic Drugs as Emerging Immune Modulators in CancerCarmine Stolfi, Teresa Pacifico, Anderson Luiz-Ferreira, et al.
Biomedicines|July 29, 2025
Repurposing Rafoxanide: From Parasite Killer to Cancer FighterTeresa Pacifico, Lorenzo Tomassini, Livia Biancone, et al.
Cancers|February 11, 2023
Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy ResistanceGiovanni Monteleone, Eleonora Franzè, Claudia Maresca, et al.
Frontiers in Immunology|July 15, 2022
Targeting IL-34/MCSF-1R Axis in Colon CancerGiovanni Monteleone, Claudia Maresca, Marco Colella, et al.
International Journal of Molecular Sciences|December 9, 2023
TRAIL-Sensitizing Effects of Flavonoids in CancerAnderson Luiz-Ferreira, Teresa Pacifico, Álefe Cardoso Cruz, et al.
Journal of Crohn'S & Colitis|July 2, 2024
Bromodomain-containing 4 is a positive regulator of the inflammatory cytokine response in the gutEleonora Franzè, Federica Laudisi, Claudia Maresca, et al.
Cancer Science|September 6, 2024
Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesisTeresa Pacifico, Carmine Stolfi, Lorenzo Tomassini, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Biomedicines|July 29, 2023
Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus BarrierCarmine Stolfi, Teresa Pacifico, Giovanni Monteleone, et al.
Biomedicines|May 27, 2026
From Gut Homeostasis to Colorectal Cancer: Spatial and Temporal Reprogramming of Microbial Inosine SignalingLorenzo Tomassini, Teresa Pacifico, Giovanni Monteleone, et al.
Cells|December 24, 2025
Targeting Cancer Cell Energy Metabolism in Colorectal Cancer: Opportunities and Challenges from Drug RepositioningLorenzo Tomassini, Teresa Pacifico, Giovanni Monteleone, et al.
International Journal of Molecular Sciences|April 13, 2023
Anthelmintic Drugs as Emerging Immune Modulators in CancerCarmine Stolfi, Teresa Pacifico, Anderson Luiz-Ferreira, et al.
Biomedicines|July 29, 2025
Repurposing Rafoxanide: From Parasite Killer to Cancer FighterTeresa Pacifico, Lorenzo Tomassini, Livia Biancone, et al.
Cancers|February 11, 2023
Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy ResistanceGiovanni Monteleone, Eleonora Franzè, Claudia Maresca, et al.
Frontiers in Immunology|July 15, 2022
Targeting IL-34/MCSF-1R Axis in Colon CancerGiovanni Monteleone, Claudia Maresca, Marco Colella, et al.
International Journal of Molecular Sciences|December 9, 2023
TRAIL-Sensitizing Effects of Flavonoids in CancerAnderson Luiz-Ferreira, Teresa Pacifico, Álefe Cardoso Cruz, et al.
Journal of Crohn'S & Colitis|July 2, 2024
Bromodomain-containing 4 is a positive regulator of the inflammatory cytokine response in the gutEleonora Franzè, Federica Laudisi, Claudia Maresca, et al.
Cancer Science|September 6, 2024
Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesisTeresa Pacifico, Carmine Stolfi, Lorenzo Tomassini, et al.
Pageof 2